Perbedaan DCI Indonesia Tbk dan Cipta Sarana Medika Tbk.: DCI Indonesia Tbk diperdagangkan di Rp198.675 (kapitalisasi pasar 473,71 T, volume 24 jam 1 rb), sedangkan Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt). Perbedaan utamanya: DCI Indonesia Tbk jauh lebih besar — sekitar 2995,9× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Cipta Sarana Medika Tbk. lebih aktif diperdagangkan (8,21 jt vs 1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DCII | DKHH | |
|---|---|---|
Kapitalisasi Pasar | 473,71 T | 158,12 M |
Volume | 1 rb | 8,21 jt |
Lot | 10 | 82,15 rb |
Perputaran | 194,12 jt | 515,2 jt |
Harga Rata-rata | 194.120 | 62,72 |
Nilai Transaksi | 194,12 jt | 515,2 jt |
Harga Ekuilibrium Indikatif | 199.000 | 63 |
Volume Ekuilibrium Indikatif | 1 | 1,33 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Selengkapnya di halaman DCII →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →